Drug Study Vitamin K

Republic of the Philippines
Cebu Normal University

Osmeña Blvd., Cebu City, 6000, Philippines
College of Nursing
Telephone No.: (+63 32) 254 4837
Email: cn@cnu.edu.ph
Website: www.cnu.edu.ph
DRUG STUDY
Patient’s Initials:ABC Date of Admission:September 21,2022 Diagnosis: Normal Baby Delivery

Age: ____________________________ Height: 58 cm Weight.:2400 grams Clinical Intervention: Administration of Intramuscular Injection
Sex:Female Ward: ____________ Bed No.: ____________ Name of Physician: Virginio Garces
Drug Information Classification Mechanism of Action Indication Contraindications Side Effects Nursing Responsibilities
Generic Name: Pharmacologic Pharmacodynamics or General Vitamin K use requires (per system preferably) Before Drug Administration:
Vitamin K Classification: Mechanism of Action: Indication/s: caution in neonates, GI: 1. Make sure the patient is aware of the benefits
Anticoagulants Vitamin K is a cofactor ofOral phylloquinone patients with hereditary Decreased appetite of the medication
Trade Name: gamma-carboxylase.7,8 is indicated to treat hypoprothrombinemia, irritability 2. Take note of the time, date and route of the
Aquamephyton, Gamma carboxylaseprothrombin renal impairment, cases Respiratory: medication administered
Infuvite, Infuvite attaches carboxylic acid deficiency caused of over anticoagulation Difficulty in swallowing 3. Prepare materials needed for the
Pediatric, Mephyton, functional groups to by coumarin or due to heparins, and lightheadedness or administration of medication
Mvi Pediatric, glutamate, allowing
indanedione hypersensitivity to fainting
Phytonadione precursors of factors II, derivatives; and vitamin K. shortness of breath During Drug Administration:
VII, IX, and X to bind hypoprothrombine troubled breathing and/or 1. Draw back on the plunger of the syringe
Minimum Dose: Therapeutic calcium ions.6 Binding of mia secondary to wheezing before injection to avoid intravascular
0.05 ml Classification: calcium ions converts antibacterial Skin: injection
Coagulant these clotting factors to therapy, skin rash, hives and/or 2. After administering 0.1 ml of Vitamin K, take
Maximum Dose: their active form, which salicylates, or itching note of any adverse reactions
Not > than 0.1 ml are then secreted from obstructive Blue color or flushing or
hepatocytes into the jaundice or biliary redness of skin After Drug Administration:
Patient’s Dose: blood, restoring normal fistulas with swelling of eyelids, face, 1. Document the time, date and administration
0.1 ml clotting function.18 concomitant bile or lips route of the medication.
salt administration. muscle stiffness
Route: Vitamin K may also These indications paleness
Intramuscular (IM) carboxylate matrix include the above general body swelling
proteins in chondrocytes, indications as well
College of Nursing
Telephone No.: (+63 32) 254 4837
Frequency: inhibiting calcification of as Cardio:
After delivery of the joints, and may increase hypoprothrombine tightness in chest
newborn baby type II collagen.10 The mia secondary to fast and/or weak
role of vitamin K in sprue, ulcerative heartbeat
Availability/Form: osteoarthritis,10 bone colitis, celiac low blood pressure
Injectable solution density,11 and vascular disease, intestinal (temporary)
calcification12 is currently resection, fast or irregular breathing
Contents: under investigation. pancreatic cystic
Vitamin K1 Injection fibrosis, or
(Phytonadione Pharmacokinetics: regional enteritis;
Injectable Emulsion, Absorption: IM or
USP) is a yellow, hypoprothrombine
sterile, nonpyrogenic mia caused by
aqueous dispersion interference with
available for injection vitamin k
by the intravenous, metabolism
intramuscular and
subcutaneous Patient’s
routes. Each milliliter Indication:
contains Parenteral
phytonadione 2 or 10 (intravenous,
mg, polyoxyethylated intramuscular, and
fatty acid derivative subcutaneous)
70 mg, dextrose, phylloquinone is
hydrous 37.5 mg in indicated to treat
water for injection; coagulation
benzyl alcohol 9 mg disorders due to
added as faulty formation of
College of Nursing
Telephone No.: (+63 32) 254 4837
preservative. May coagulation factors
contain hydrochloric II, VII, IX, and X
acid for pH caused by vitamin
adjustment. pH is 6.3 K deficiency or
(5.0 to 7.0). some interference
with vitamin K
activity.
References (at least 2):

Forestier, F., Daffos, F., Rainaut, M., Solé, Y., & Amiral, J. (1985). Vitamin K dependent proteins in fetal hemostasis at mid trimester of pregnancy. Thrombosis and haemostasis, 53(03), 401-403.
Owen, G. M., Nelsen, C. E., Baker, G. L., Connor, W. E., & Jacobs, J. P. (1967). Use of vitamin K1 in pregnancy: Effect on serum bilirubin and plasma prothrombin in the newborn. American Journal of Obstetrics and Gynecology,
99(3), 368-373.
College of Nursing
Telephone No.: (+63 32) 254 4837
PRODUCT ASSESSMENT RUBRICS FOR DRUG STUDY
Student Name: ___________________________________ Year/Section: ____________________ Date: __________________ Score: ___/30
Directions: Please select the appropriate rating using the following descriptions.
Element Very Satisfactory Satisfactory Needs Improvement Comments

Drug ☐ Accurately presented all of the patient and drug information ☐ Accurately presented most of the patient and drug ☐ Accurately presented some of the patient and drug information
Information (name [brand & generic], dosage [patient’s dose; min. & max], information related to the case. 1 missing information or error related to the case. 2 or more missing information or errors noted.
(10%) frequency, route, availability, contents) related to the case. [3] noted. [2] [1]
Classification ☐ Accurately presented the classification (therapeutic and ☐ Accurately presented the classification related to the drug ☐ Inaccurately presented the classification related to the drug.
(10%) pharmacologic) related to the drug. [3] but with 1 irrelevant information or error noted. [2] Classification is not relevant to the drug. [1]
☐ Accurately presented the indication/s (general & ☐ Accurately presented the indication/s related to the drug ☐ Inaccurately presented the indication/s related to the drug.
Indication (10%)
patient-specific) related to the drug. [3] but with 1 irrelevant information or error noted. [2] Indication is not relevant to the drug. [1]
Mechanism of ☐ Accurately presented the mechanism of action ☐ Accurately presented the mechanism of action of the drug ☐ Inaccurately presented the mechanism of action of the drug.
Action (10%) (pharmacokinetics, pharmacodynamics) of the drug. [3] but with 1 irrelevant information or error noted. [2] Mechanism of action is not relevant to the drug. [1]
☐ Accurately presented all of the common contraindications ☐ Accurately presented most of the common ☐ Accurately presented some of the common contraindications
Contraindicatio related to the drug. [3] contraindications related to the drug. 1 missing information related to the drug. 2 or more missing information or errors noted.
n (10%) or error noted. [2] [1]
☐ Accurately presented all of the common side effects related to ☐ Accurately presented most of the common side effects ☐ Accurately presented some of the common side effects related
Side Effects
the drug. [3] related to the drug. 1-2 missing information or errors noted. to the drug. 3 or more missing information or errors noted. [1]
(10%)
[2]
Nursing ☐ Accurately presented all of the common nursing ☐ Accurately presented most of the common nursing ☐ Accurately presented some of the common nursing
Responsibilities responsibilities (before, during, and after) related to the drug. [9] responsibilities related to the drug. 1-2 missing information responsibilities related to the drug. 3 or more missing information
(30%) or errors noted. [7] or errors noted. [3]
☐ Presented at least 2 sources that are updated (within 5 years), ☐ Presented only one source that is updated (within 5 years), ☐ No source was presented. Sources are not updated (more than 5
References
relevant, and credible. [3] relevant, and credible. Other sources are not updated, credible years), relevant, and credible. [1]
(10%) or relevant. [2]
Sub-score = ____ = ____ = ____
Evaluated by:
College of Nursing
Telephone No.: (+63 32) 254 4837
_______________________________________
Signature over Printed Name of Clinical Instructor

Drug Study Vitamin K

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Drug Study Vitamin K

Uploaded by

Copyright:

Available Formats

Republic of the Philippines

Cebu Normal University

Patient’s Initials:ABC Date of Admission:September 21,2022 Diagnosis: Normal Baby Delivery

References (at least 2):

PRODUCT ASSESSMENT RUBRICS FOR DRUG STUDY

Student Name: ___________________ Year/Section: Date: Score: _/30

Element Very Satisfactory Satisfactory Needs Improvement Comments

You might also like